Dublin, Sept. 04, 2020 (GLOBE NEWSWIRE) -- The "US Ankylosing Spondylitis Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive insights into Ankylosing Spondylitis pipeline products, Ankylosing Spondylitis epidemiology, Ankylosing Spondylitis market valuations and forecast, Ankylosing Spondylitis drugs sales and competitive landscape in the US.
The research is classified into seven sections - Ankylosing Spondylitis treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
- Ankylosing Spondylitis pipeline: Find out the products in clinical trials for the treatment of Ankylosing Spondylitis by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Ankylosing Spondylitis epidemiology: Find out the number of patients diagnosed (prevalence) with Ankylosing Spondylitis in the US
- Ankylosing Spondylitis drugs: Identify key products marketed and prescribed for Ankylosing Spondylitis in the US, including trade name, molecule name, and company
- Ankylosing Spondylitis drugs sales: Find out the sales revenues of Ankylosing Spondylitis drugs in the US
- Ankylosing Spondylitis market valuations: Find out the market size for Ankylosing Spondylitis drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
- Ankylosing Spondylitis drugs market share: Find out the market shares for key Ankylosing Spondylitis drugs in the US
Benefits of this Research
- Support monitoring and reporting national Ankylosing Spondylitis market analysis and sales trends
- Track competitor drugs sales and market share in the US Ankylosing Spondylitis market
- Track competitive developments in Ankylosing Spondylitis market and present key issues and learnings
- Synthesize insights for Ankylosing Spondylitis market and products to drive business performance
- Answer key business questions about the Ankylosing Spondylitis market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Ankylosing Spondylitis products
- Supports decision making in R&D to long term marketing strategies
Key Topics Covered
1) Ankylosing Spondylitis Treatments
2) Ankylosing Spondylitis Pipeline
3) US Ankylosing Spondylitis Epidemiology
4) Marketed Drugs for Ankylosing Spondylitis in US
5) US Ankylosing Spondylitis Market Size and Forecast
6) US Ankylosing Spondylitis Products Sales and Forecast
7) US Ankylosing Spondylitis Market Competitive Landscape
8) Methodology
List of Tables
1. Ankylosing Spondylitis Phase 3 Clinical Trials, 2020
2. Ankylosing Spondylitis Phase 2 Clinical Trials, 2020
3. Ankylosing Spondylitis Phase 1 Clinical Trials, 2020
4. Ankylosing Spondylitis Epidemiology, US, 2016 - 2025
5. Marketed Drugs for Ankylosing Spondylitis, US, 2019
6. Ankylosing Spondylitis Market Size and Forecast ($), US, 2016 - 2025
7. Ankylosing Spondylitis Product Sales ($), US, 2016 - 2025
List of Figures
1. Ankylosing Spondylitis Epidemiology, US, 2016 - 2025
2. Ankylosing Spondylitis Market Size and Forecast ($), US, 2016 - 2025
3. Ankylosing Spondylitis Products Market Share (%), US, 2019
For more information about this report visit https://www.researchandmarkets.com/r/u0bx6h
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900